United Kingdom

Synonyms: 
U.K.
UK
Wales
Britain
England
Fri
04
Oct

Plans for comprehensive analytical testing review for UK cannabis industry

The Centre for Medicinal Cannabis (CMC) has outlined their plans to undertake a comprehensive review of analytical testing for the cannabis industry.

Recent market research commissioned by CMC demonstrated that CBD and related cannabinoids are gaining rapid expansion in products aimed at wellness and medicinal markets.

Tue
01
Oct

Jamaica partnership with Harvard Institute to help Island cannabis compete worldwide

Jamaica is looking to gain a competitive edge in the worldwide cannabis market by partnering with the American Harvard International Phytomedicines and Medical Cannabis Institute (HIPI).

Jamaican minister Audley Shaw has announced the island’s Ministry of Industry, Commerce Agriculture and Fisheries will team with HIPI to focus on developing various initiatives intended to provide Jamaica with that competitive edge.

Tue
01
Oct

While Lawmakers discourage vaping in US, doctors in the UK promote it

While the U.S. scrambles to crack down on vaping, Britain has embraced electronic cigarettes as a powerful tool to help smokers kick the habit.

The Royal College of Physicians explicitly tells doctors to promote e-cigarettes “as widely as possible” to people trying to quit. Public Health England’s advice is that vaping carries a small fraction of the risk of smoking.

Mon
30
Sep

Can marijuana help treat autism symptoms? A new study aims to find out

Tucked away in the quiet English countryside on more than 47 acres, GW Pharmaceuticals is doing something no other drug company can do: produce the only cannabis-based medication ever approved by the US Food and Drug Administration.​

Fri
27
Sep

Epidyolex approved for use in over 30 European Countries

Patients in over 30 European countries could soon be able to get access to GW Pharmaceuticals Epidyolex cannabis medicine after it was approved by the European Commission.

Since its launch in the U.S last year GW’s sales have rocketed with Epidiolex (as it is known in America) boosting its revenues by over $30m in its first quarter, with more than 7,600 patients accessing the drug.

Now the European Medicines Agency has approved marketing authorisation in the 28 member states of the European Union, for its use for two conditions associated with childhood epilepsy; Lennox‑Gastaut syndrome and Dravet syndrome.

Wed
25
Sep

UK farming union urges growing hemp for building materials

The UK’s National Farming Union (NFU) encourages British farmers to plant hemp for building materials in a new report that sets out a plan to make the agricultural sector carbon neutral by 2040.

Tue
24
Sep

Cannabis-based drug for childhood epilepsy approved for use in UK

The first cannabis-based medicine for childhood epilepsy is expected to be available soon in the UK and the rest of Europe after its UK manufacturer, GW Pharmaceuticals, received the green light from European authorities.

Cambridge-based GW said the European Medicines Agency (EMA) and the European commission had approved Epidyolex for seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome (LGS) and Dravet syndrome for patients aged two years and older.

Tue
24
Sep

Experts in the UK want medical marijuana to be available for free

A group of hundreds of professors, health experts, doctors, and politicians across UK political parties have signed on to letters calling for medical marijuana to be available for free in the United Kingdom. To make medical cannabis available at no cost to patients, prescriptions have to come from the National Health Service (NHS), the UK’s comprehensive, universal, and free-at-the-point-of-service medical system.

Mon
23
Sep

London to replace Frankfurt as Europe’s cannabis capital hub

While Frankfurt is the current market of choice for overseas companies, the additional capital available in London will see it become Europe’s financial cannabis hub, say experts.

Jonathan Roy, a Director at the Cannabis Investor Forum, said the U.K. investment opportunities are currently limited to a few companies as others ‘play a waiting game’.

Fri
20
Sep

Medical cannabis could nip Britain’s growing opioid crisis in the bud

The United States is suffering from an epidemic that is estimated to have claimed 400,000 lives. In what is now known as the opioid crisis, drug manufacturers have been raking in huge profits over the past two decades by mass prescribing a diverse class of addictive painkillers known as opioids.

Now, about 130 people in the United States die every day after overdosing on opioids, making it the nation’s biggest accidental killer, while millions more continue to suffer from the dependence and addiction that the drugs cause. 

Things reached a boiling point this week after drug-maker Purdue Pharma filed for bankruptcy and agreed to a $12bn settlement for its role in fuelling the crisis. 

Pages

Subscribe to RSS - United Kingdom